4//SEC Filing
CURAGEN CORP 4
Accession 0001030653-09-000020
CIK 0001030653operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:20 PM ET
Size
14.8 KB
Accession
0001030653-09-000020
Insider Transaction Report
Form 4
CURAGEN CORPCRGN
ZENNER PATRICK J
Director
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-10-01−35,000→ 0 totalExercise: $0.57Exp: 2010-10-01→ Common Stock (35,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-10-01−17,500→ 0 totalExercise: $1.09Exp: 2010-10-01→ Common Stock (17,500 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-10-01−15,000→ 0 totalExercise: $2.73Exp: 2010-10-01→ Common Stock (15,000 underlying) - Disposition to Issuer
Common Stock
2009-10-01−10,000→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-10-01−17,500→ 0 totalExercise: $0.69Exp: 2010-10-01→ Common Stock (17,500 underlying)
Footnotes (5)
- [F1]Disposed of pursuant to merger agreement between issuer and Celldex Therapeutics, Inc. in exchange for 2,739 shares of Celldex Therapeutics, Inc. common stock having a market value of $19.82 per share on the effective date of the merger, October 1, 2009.
- [F2]This option, which vested 100% on May 2, 2007, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 4,108 shares of Celldex Therapeutics, Inc. common stock for $9.97 per share.
- [F3]This option, which vested 100% on January 24, 2008, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 4,793 shares of Celldex Therapeutics, Inc. common stock for $2.52 per share.
- [F4]This option, which vested 100% on May 21, 2008, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 4,793 shares of Celldex Therapeutics, Inc. common stock for $3.98 per share.
- [F5]This option, which vested 100% on February 11, 2009, was assumed by Celldex Therapeutics, Inc. in the merger and replaced with an option to purchase 9,586 shares of Celldex Therapeutics, Inc. common stock for $2.08 per share.
Documents
Issuer
CURAGEN CORP
CIK 0001030653
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001030653
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:20 PM ET
- Size
- 14.8 KB